期刊
JOURNAL OF NEUROSCIENCE
卷 26, 期 41, 页码 10480-10487出版社
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.3231-06.2006
关键词
A beta peptide; Alzheimer's disease; signal transduction; actin; calcium; cAMP; transport
资金
- NINDS NIH HHS [R29 NS036241, NS36241, R01 NS036241] Funding Source: Medline
Defects in axonal transport are often associated with a wide variety of neurological diseases including Alzheimer's disease (AD). beta-Amyloid (A beta) is a major component of neuritic plaques associated with pathological conditions of AD brains. Here, we report that a brief exposure of cultured hippocampal neurons to A beta molecules resulted in rapid and severe impairment of mitochondrial transport without inducing apparent cell death and significant morphological changes. Such acute inhibition of mitochondrial transport was not associated with a disruption of mitochondria potential nor involved aberrant cytoskeletal changes. A beta also did not elicit significant Ca2+ signaling to affect mitochondrial trafficking. However, stimulation of protein kinase A (PKA) by forskolin, cAMP analogs, or neuropeptides effectively alleviated the impairment. We also show that A beta inhibited mitochondrial transport by acting through glycogen synthase kinase 3 beta (GSK3 beta). Given that mitochondria are crucial organelles for many cellular functions and survival, our findings thus identify an important acute action of A beta molecules on nerve cells that could potentially contribute to various abnormalities of neuronal functions under AD conditions. Manipulation of GSK3 beta and PKA activities may represent a key approach for preventing and alleviating A beta cytotoxicity and AD pathological conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据